Vetted Innovators

4D Biomaterials is developing and commercializing resorbable photocurable resins for a wide range of implantable medical device applications. The company's 4Degra biomaterials are 3D printed and tailored based on the needs of the implants, from softer grades for meshes, and films to harder formulations for pins, screws, and load-bearing bone regeneration scaffolds. 4D Biomaterials currently offers three grades of its T-Series material, from the flexible T15 to the most supportive T2500.

Visit website.

Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.

Visit website.

AccurKardia is a digital-first and software-only healthcare company focused on enabling a world in which a combination of smart devices, reliable and actionable data, and efficient clinical intervention can together improve medical outcomes and save lives. AccurKardia provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies

Visit website.

Acorai is developing a non-invasive monitoring solution to measure pulmonary artery pressure. The handheld device utilizes a unique combination of acoustic, electrocardiographic, pressure, seismic and visual sensors to collect robust data to be analyzed using a machine learning engine to evaluate heart failure progression. The company's solution is an alternative to the current standard procedure, which involves right heart catheterization performed in a catheterization lab to evaluate heart functionality.

Visit website.

Adaptix is developing an innovative, miniaturized flat panel X-ray source and associated software to transform existing X-ray systems into Digital Tomosynthesis systems to expand patient access to low-dose 3D imaging. 

Visit website.

Adlore's mission is to develop better solutions for people with chronic wounds. The company's first product, SenLore, is a smart boot to improve the healing of diabetic foot ulcers. The device utilizes electrical and heat-based stimulation to increase blood flow. SenLore also features integrated biosensors that provide feedback to monitor the effectiveness of wound healing. 

Visit website.

Advamedica are taking their deep expertise in novel biomaterials to develop products for hemostasis and wound management. The company's latest product, Ax-Surgi is a surgical hemostatic patch that helps to control severe Class III, Class IV bleeding in surgeries. Advamedica also develops hemostats for vascular access sites, military bleeding control that are being marketed in many countries globally. 

Visit website.

Advanced Bifurcation Systems is developing a solution to simplify and enhance the effectiveness of stenting of coronary arteries at bifurcations. The ABS platform ensures automatic alignment and perfect positioning of a bifurcating stent to evenly scaffold a bifurcation. 

Visit website.

A deep-tech optical scanning company that provides robotic, navigation, and AR/VR platforms with new capabilities to enhance surgeon and patient experience.     

Visit website.

AIRAmed develops AI-based software solutions to improve medical care for neurodegenerative diseases. The company's lead product, AIRAscore, uses neural networks to analyze and quantify global and regional brain volumes from MRI images to detect deviations from the normal ageing process of the brain.

Visit website.

Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more. The company's remote patient monitoring platform is being developed as an alternative to one-metric devices and consumer-grade sensors (i.e. fitness trackers) that do not capture clinical-grade data.

Visit website.

Allheartz is developing novel clinical AI-powered digital solutions to revolutionize home care in musculoskeletal (MSK) and sports health. The Software as a Medical Device (SaMD) platform innovated through the company's proprietary advanced computer vision applications turn an individual's smartphone into a medical-grade sensor. The platform is coupled with a remote HIPAA-compliant SaaS platform, to cut hospital costs while generating revenue through Remote Therapeutic Monitoring, simultaneously providing integrated, personalized, portable medicine that enables new highly scalable community-wide preventative care systems and value models.

Visit website.

Alucent Biomedical is focused on transforming the way vascular disease is treated. The company is developing a proprietary catheter-based solution called Natural Vascular Scaffolding (NVS). The technology utilizes photoactivation of a small molecule drug delivered endovascularly to create a natural, stent-like scaffold using the body's own tissue and processes.

Visit website.

Innovative non-invasive devices for assessment and management of musculoskeletal function

Visit website.

Coronary artery disease (CAD) is society's biggest killer. When not proactively managed, the disease requires costly surgical interventions that can carry post-surgical risks to patients. AMT Medical has developed a suture-less medical device that makes open-heart surgery less complex for interventionists and safer for patients. To-date, the company's patented solution has been successfully utilized in 10 patients in a first-in-human trial.

VIsit website.

Amynas is developing a bioresorbable envelope composed of millions of drug-coated immunomodulatory electrospun nanofibers designed to promote healthy tissue growth around implanted devices. The company's mission is to reduce implant-related infections and eliminate the dependence on antibiotics.

Visit website.

Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average.

Visit website.

Aptitude Medical Systems is harnessing nature's most versatile material, nucleic acids, to develop innovative diagnostic devices and medicines. The company has created a simple, efficient diagnostic testing device that can be used by anyone, anywhere. 

VIsit website.

Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy.

Visit website.

Arga Medtech is developing a next-generation solution for the treatment of cardiac arrhythmia and atrial fibrillation. The company's Coherent Sine-burst Electroporation (CSE) uses a proprietary puled-field ablation (PFA) generator and catheter to offer a single-shot device capable of producing linear and focal lesions safer, more efficiently and faster than existing technologies used to treat cardiac arrhythmias today.

Visit website.

Aspero Medical is addressing current limitations of endoscopic devices used to diagnose and treat small bowel disease. Current device must minimize pressure to prevent mucosal damage, which limits the anchoring force of the balloon. Aspero Medical's Pillar balloon solution features patented pillar micro-textures that maximize frictional properties, increasing anchoring consistency navigating the GI tract, reducing procedure time, and improving patient care.

Visit website.

Long-term, non-thermal resolution of atrial fibrillation. AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF). This non-thermal approach targets hyperactive cell structures on the outside of the heart and disrupts the errent electrical signals that are responsible for AF, while sparing healthy tissue.  

Visit website.

Avatar Medical creates patient avatars in virtual reality to allow surgeons to visualize medical images. The company's solution generates 3D models based on patient-specific images. These models are lossless and are generated in real-time to provide an accurate and instantaneous means for clinicians to understand their patient's medical image.

Visit website.

VisiPlate is a nanoscale aqueous shunt that aims to treat mid to late-stage glaucoma.  VisiPlate is 20x thinner than a human hair.

Visit website.

BeCare Link's BeCare MS Link is a digital health solution to help patients with multiple sclerosis (MS) manage their condition. The app provides quantifiable assessments of neurologic function and cognition on demand, while simultaneously offering healthcare providers comprehensive and timely data to monitor and improve patient care.

Visit website.

Berkshire Biomedical Corporation is developing drug delivery devices by pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems to provide accurate personalized medication delivery to the authenticated Intended User.  The Company’s lead product under development, the Computerized Oral Prescription Administration (COPATM) System, is an authenticated Intended User automated oral liquid dispensing system designed to deliver controlled and non-controlled liquid oral medications to only the Intended User upon confirmation of fingerprint and dentition biometric identification. 

Visit website.

BioGend Therapeutics specializes in the development of advanced biomaterials for bone and joint repair and restoration. The company's lead product, RevoCart, is commercially available in Taiwan for the repair of cartilage defects of the knee. BioGend's R&D team is currently developing biologically-active bone grafts containing an osteoinductive factor similar to rhBMP-2. 

Visit website.

BioMEMS Diagnostics has developed a simple-to-use, extremely sensitive and affordable POC testing platform that allows new and esoteric tests to be developed and deployed in months instead of years. A handheld portable device and single-use test cartridge produce results in under 5 minutes and ports them to a paired smart device, displacing the current paradigm of collecting samples, transporting to a remote lab, and waiting for results when sophisticated or especially sensitive tests are needed.

Visit website.

BVT Bionic Eye System, the world’s first suprachoroidal visual implant, to restore functional vision to the blind suffering from inherited retinal diseases.

Visit website.

BioT's cloud platform simplifies the creation of a connected care ecosystem. The platform is self-service and requires no coding to connect medical devices, patient management portals, caregivers, and EHRs in an integrated space.

Visit website.

Blue Halo BioMedical's Blue Halo Coil Catheter is a fully internal male urologic catheter. The company's device does not require an external collection device and is designed to have superior flow rates compared to competing catheters - features designed to improve the qualify of life in urologic patients.

Visit website.

Novel medical devices to enhance the reliability and safety of orthopedics procedures. 

Visit website.

Body Vision's fusion imaging platform enables pulmonologists, for the first time, to use all the existing imaging modalities together, in real time, without changing or affecting the procedural flow. The Body Vision System, together with a unique delivery device, enables the physician to plan the procedure, navigate to challenging locations and localize the lesion during biopsy. This complete solution will facilitate early-stage diagnosis of lung cancer and, in addition, will pave the way for minimally invasive transcatheter therapeutics.

Visit website.

BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians.

Visit website.

Innovative devices using proprietary acoustic and accelerometer technology to diagnose sleep apnea.

Visit website.

Brinter is a BioTech/MedTech company from the US and Finland. With the company's commercial & patented 3D bioprinter and biomaterials, Brinter develops cartilaginous applications for regenerative medicine, such as meniscus, nose, ear, hip socket, and faceted joint cartilage. The company licenses these applications for clinics, hospitals, and ambulatory surgical centers for reconstructive and cosmetic surgery.

Visit website.

BURL Concepts' SONAS is a portable, battery-powered ultrasound system that enables non-invasive brain perfusion assessment at the point-of-care. SONAS is used in combination with microbubble contrast agents to evaluate unilateral and bi-lateral cerebral perfusion.

Visit website.

Butterfly Medical is developing an innovative treatment for benign prostatic hyperplasia (BPH). The company's implantable device can be inserted without surgery to provide relief from symptomatic BPH. The implantation procedure can be performed in under ten minutes in a physician's office using local anesthesia.

Visit website.

Byonyks mission is to provide affordable dialysis care to millions of patients worldwide suffering from renal failure. The company is developing Byonyks X1, a bloodless dialysis machine for kidney failure patients. The device is a portable, noninvasive alternative to current solutions on the market that is intended to make dialysis more accessible to patients requiring this vital care. 

Visit website.

CAIRA is developing software for advanced joint replacement. The software utilizes radar technology to improve navigation during manual and robotic surgery. The company's first product is a navigation system for use during knee replacement surgery.

Visit website.

CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins.

Visit website.

Cambridge Medical Technologies' LabClasp is an oximeter-like device capable of noninvasively detecting and monitoring blood biomarkers in real-time. The technology enables a stream of trended blood-chemistry data that enables highly personalized precision medicine, while substantially reducing patient risk and healthcare costs.

Visit website.

Capella Imaging is a biogenerator company focused on the development of diagnostic imaging agents to support unmet medical needs. The company's lead candidate is a fibrin-targeted diagnostic imaging agent for cardiac imaging. FibroScint[P1]  (Tc-99m F4A] is a fibrin-targeted, peptide compound labeled with the radioisotope technetium-99m (Tc-99m) for SPECT imaging. The technology will have potential applications across multiple cardiovascular conditions such as thrombus (blood clots) associated with left ventricular assist devices (LVADs), deep vein thrombosis, pulmonary embolism and acute coronary syndrome. 

Visit website.

CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. 

Visit website.

Caretaker Medical’s VitalStream™ Wireless Hemodynamic Monitoring platform is FDA-cleared to Non-invasively measure Continuous Beat-by-Beat Blood Pressure, Cardiac Output, Fluid Response, and other Advanced Hemodynamic parameters for ICU-quality continuous Remote Patient Monitoring across the full care continuum.

 The company’s patented Pulse Decomposition Analysis™ AI Technology, wearable Finger Sensor and remote App provide a wire-free alternative to invasive A-Lines and catheter-based hemodynamics and eliminates blind-spots between intermittent measurements to enable early warning of deterioration and guide better clinical decision-making.

Visit website.

CARMAT develops and commercializes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. Once implanted, the device replicates the physiological actions of a normal heart, providing mechanical circulatory support and restoring normal blood flow through the body. With proprietary embedded electronics, Aeson is autoregulates output in response to a patient's physiological needs.

Visit website.

A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.

Visit website.

Transforming surgical drainage with intelligent digital devices to reduce complications and costs in patients recovering from cardiothoracic surgery.

Visit website.

In the future, measuring things inside the body will be as easy as taking your blood pressure.  Having precise data and measurements in real time is becoming more and more critical for the doctor and care giver while performing medical procedures and diagnosis.  Cephasonics is leading the way in using AI and ultrasound data to  non-invasively automatically detect, identify, characterize and measure things in the body without the need for a trained professional.  Today, Cephasonics is the only company to provide a complete FDA-ready HW & SW OEM ultrasound platform that provides unfettered access to ultrasound data and enables AI for clinical applications that support medical procedures and diagnosis with precise data about key aspects of a medical procedure in real time.

Visit website.

Ceresti has built a digital health program—and conducted the clinical studies—to prove that activating family caregivers improves the quality, experience and cost of care for frail elderly Medicare Advantage members, including those living with Alzheimer’s / dementia. 

Visit website.

Cern is developing a medical device for the treatment of bacterial and yeast vaginosis. The device uses low-level microbicidal light at specific wavelengths to induce oxidative stress at the DNA level in bacteria and yeast cells - inhibiting the ability of these cells to reproduce. The Cern Device represents a drug-free alternative for millions of women with vaginosis/vaginitis. 

Visit website.

The company is dedicated to innovation in cancer care and recently launched IQwave. This technology performs electrochemotherapy which is approved for the treatment of a wide range of tumors. 

Visit website.

ClearIT is an emerging medtech company developing a new, painless, single treatment for tattoo removal. The company's ERASER System is a non-laser-based approach to tattoo removal. The device dislodges tattoo ink at room temperature through the creation of a benign, safe reactive energy field that works regardless of tattoo or skin color. 

Visit website.

Cognoa is a pediatric behavioral health company that is using artificial intelligence (AI) to power digital diagnostic and therapeutic products. The company's lead product, Canvas Dx, is an FDA-authorized diagnostic aid for early autism diagnosis. Other products in development at Cognoa include a therapeutic solution for autism, as well as diagnostic and therapeutic solutions targeted speech disorders, ADHD, and anxiety.

Visit website.

CoLabs is developing The Ventor, an emergency airway and ventilation system to manage the patients airway during cardiac arrest. 

Visit website.

An innovative intraluminal bypass device, preventing the profound clinical and economic pains associated with anastomotic leaks and diverting colonic stomas.

Visit website.

Conavi Medical is a pioneer in advanced imaging systems for minimally invasive heart procedures. The company's Novasight Hybrid System enables simultaneous and co-registered imaging of coronary arteries using both intravascular ultrasound (IVUS) and optical coherence tomography (OCT). Foresight ICE is Conavi's intracardiac echo (ICE) system that is capable of acquiring 2D and 3D images of the heart with a full 360 degree field-of-view. 

Visit website.

ConnCons is developing smart medical consumables that will enable complete and automated control of infusions, dialysis, ventilation by software. The company's mission is to make these therapies safer, more efficient, and patiently friendly.

Visit website. 

Cold cap therapy is a commonly used solution to prevent hair loss in patients undergoing chemotherapy. Cooler Heads is developing a novel cold cap system for cancer patients that has been designed to be easier to use and more affordable than existing solutions.

Visit website.

CoraVie Medical is developing a subcutaneous blood pressure monitor for patients with uncontrolled hypertension. The company's device is an implantable system intended to provide continuous, circadian blood pressure monitoring to inform treatment decisions and prevent the progression of cardiovascular disease. 

Visit website.

CorFlow is developing a device that will diagnose microvascular obstructions (MVO) in real-time during a PCI. MVO, also known as no-reflow phenomenon, is a complication that is encountered during coronary angioplasty in acute myocardial infarction patients. 

Visit website.

CorInnova is developing a minimally invasive, soft robotic cardiac device for the short-term treatment of acute heart failure. The device gently conforms to the heart's surface, applying compressions to increase cardiac output without contacting the blood - eliminating a major risk of thrombosis and stroke.

Visit website.

CorIT Medical is developing a solution targeting the most common patient complaint to ENTs - nasal obstruction. The company's CorIT device is a single-use surgical device for the reduction of inferior turbinates in patients with obstructed breathing. 

Visit website. 

CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery. 

Visit website.

Corveus Medical is developing a one-time, catheter-based solution that provides instant relief from the debilitating symptoms of chronic heart failure. Corveus’ device performs a targeted nerve ablation that find and inactivates a sympathetic nerve branch, addressing a key driver in heart failure.

Visit website.

Covellus is developing the Intravascular Lithotripsy (IVL) Adapter to be used with the Covellus Modular Balloon System (MBS). Our modular approach to peripheral vascular balloon catheters enables combining functionalities and procedural steps into a single balloon solution, at the point of care. Adding IVL to balloon catheters of any size, length, or rated burst pressure, creates a unique solution for procedures challenged by vascular calcium.

Visit website.

CranioSense is developing a noninvasive solution to monitor intracranial pressure. The company's Intracranial Pressure (ICP) and Assessment Screening System (IPASS) is a nonsurgical alternative for measuring ICP and assisting in the management of traumatic brain injury (TBI). 

Visit website.

Cyclic Variations in Altitude Conditioning (CVAC) is a is an effort-free method for physical conditioning for individuals of all ages and activity levels to improve fitness. The CVAC process applies precisely composed rhythm-based changes to pressure, temperature and density of air to create waves of tension and relaxation. These changes simulate breathing, muscle contraction, and blow flow changes consistent with circuit, interval and strength training. 

Visit website.

Cyban's next-gen brain oxygen monitor gives providers a non-invasive solution for the monitoring of brain oxygen levels. The company's technology delivers real-time measurements in an easy-to-use device that connects with central patient monitoring systems.

Visit website.

Dasi Simulations develops predictive modeling solutions for pre-operative planning of structural heart interventions. The solutions are intended to improve the quality of care for structural heart disease patients by providing innovative personalized simulations for informed pre-op preparation toward a better quality of life for people with heart disease.

Visit website.

DataBiologics has developed an automated outcomes tracking solution to study and understand the safety and efficacy of regenerative treatments. The platform makes it simple for physicians to collect and interpret patient outcomes. DataBiologics platform will help demonstrate the safety and efficacy of treatments, make more informed decisions pertaining to patient care, run observational outcomes studies, and participate in national registries to advance the field. 

Visit website.

Day Zero Diagnostics uses whole genome sequencing and machine learning to modernize infectious disease diagnosis and treatment. DZD is developing a rapid diagnostic for sepsis that uses genomic data to identify a pathogen and to comprehensively profile its antibiotic resistance, as well as services for hospital infection control. Our goal is modernize hospital microbiology using NGS and a big-data approach. 

Visit website.

Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. Additional products in development include an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh.

Visit website.

Definition Health develops a suite of digital health solutions to simplify the surgical pathway for patients and providers. The company has developed an "end-to-end" approach that offers virtual management, pre-operative assessment, and post-operative recovery monitoring for patients undergoing elective surgeries. 

Visit website.

The patented technology is a 3D whole breast ultrasound imaging device that delivers no radiation, requires no compression, and images the entire breast with a single scan. 

Visit website.

DermaSensor is designing an affordable handheld sensor that will be able to evaluate skin for potential cancer in real-time. The device will utilize Elastic Scattering Spectroscopy technology, pioneered at Boston University and University College London, which has been found to effectively differentiate cancerous skin and other tissue in several published clinical studies.

Visit website.

Diality is a medical technology company developing a smart hemodialysis platform designed to be as capable and flexible as in-center treatment, in a fully integrated, easy-to-use system that’s intended to be safe to operate in any environment, with enough versatility to allow healthcare providers to tailor treatment to each patient’s specific needs. The Diality Hemodialysis System’s compact footprint and mobility are intended to enable it to be easily integrated into – and transported within – any dialysis setting, be it acute-care hospital, dialysis clinic, transitional care unit, traditional home, or skilled nursing facility.

Visit website.

Digistain uses proprietary optical scans of tumor tissue to offer a personalized prognostic score as to the likelihood of breast cancer recurrence in cancer treated with hormone therapy alone. The technology captures the unique spectral signature of a tumor and then analyzes over 10,000 data point with machine learning to produce an accurate risk score that has been validated on over 800 patients to date.

Visit website.

DirectSync Surgical is developing a proprietary technology to imitate the natural healing properties of bone using minute electrical stimulation. The company leverages the human body's mechanical biofeedback system to design disruptive "smart implants" that heal bone using natural bone forming pathways.

Visit website.

Discure Technologies is a stealth-mode startup dedicated to providing relief for millions of people with debilitating back pain. The company is developing a minimally invasive device intended to treat discogenic back pain by reversing degenerative disk disease, a condition associated with over 35% of all low back pain cases. The technology targets the underlying cause of the disease, restoring the disk's healthy function and eliminating pain via a bioelectronic approach.

DriQ Health is an internet-of-things (IoT) incontinence monitoring solution. The company's technology leverages sensor technology and artificial intelligence to monitor the state of a diaper or adult brief. DriQ Health provides end-users with real-time access to their data to providers work with their patients to improve their quality of life.

Visit website.

Treatment for saphenous vein grafts that strengthens the graft and reduces the intimal hyperplasia that leads to graft failure.  This treatment address three large unmet clinical markets, CABG, PAD, and AVF. 

Dymicron is an innovation-driven medical technology company that is advancing a new generation of musculoskeletal devices made from Polycrystalline Diamond (PCD)—one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use in all human interbody applications.

Visit website.

e-Scopics is democratizing ultrasound imaging for all healthcare professionals. The company manufactures a digital transducer and a connected software APP to provides quantitative imaging for several medical conditions. The image formation process is no longer hardware based but rather a SaaS running on a cell phone, a Tablet or the Cloud, with AI based algorithms for quantitative diagnosis. 

Visit website.

EchoPixel’s FDA-cleared Holographic Therapy Guidance (HTG) helps operators easily obtain, visualize and navigate a real-time 4D hologram of a patient’s heart using standard medical images. A holographic digital twin of the patient simplifies procedures allowing more operators and heart centers to take advantage of new opportunities from enhanced precision and control in the delivery of minimally invasive therapies.

Visit website.

Endiatx's Pillbot is a multivitamin-sized intrabody robot. The robot propels itself throughout the body using four pump jets and features a forward-facing camera to visualize the interior of the body. Endiatx is on a mission to make "endoscopy at home" a reality for millions of people around the world and simultaneously improve the early detection of cancers, ulcers, and more.

Visit website.

Endolumik is developing a fluorescence-guided esophagogastric calibration system (i.e. a bougie) for use in bariatric and gastric surgery. The Endolumik System uses near-infrared lighting with an intra-gastric stent to improve visualization, precision and consistency in laparoscopic and robotic surgical procedures. 

Visit website.

Endoluxe is a world-class wireless endoscopic video imaging organization launching its industry design award-winning Endoluxe EVS Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application utilizing advanced AI/ML functionality. Endoluxe is positioned to disrupt the market as a vendor agnostic platform that allows clinicians to utilize their existing investment in traditional scopes and supporting devices, utilizing a portable, integrated, and feature-rich platform at 1/10th the cost of legacy products. More information can be found at Endoluxe.com.

Visit website.

EndoQuest Robotics is developing the Endoluminal Surgical (ELS) system, a flexible endoluminal robotic surgical system. The ELS system is designed to provide surgeons with robotic support during upper and lower GI surgery. EndoQuest's robot will be able to navigate the curvature of the GI tract with instrumentation comparable to conventional two-handed surgical technique. Future applications for the platform include minimally invasive appendectomy and cholecystectomy that will be performable with no external incisions.

Visit website.

EnteroTrack has developed a simple and safe way to collect specimen to monitor the GI tract and test for GI diseases. The company's EnteroTracker is a quick, minimally invasive, office-based device to collect a liquid biopsy of mucosal content for specimen analysis. 

Visit website.

Surgical solutions that help improve suturing safety, speed and versatility.

Visit website.

Exact Imaging's Micro-ultrasound platform provides a practical solution as a new tool for urologists to perform targeted biopsies within a standard urological workflow.

Visit website.

FeelTect's Tight Alright is a connect-health platform that provides data-driven, targeted, and consistent compression therapy for the treatment of venous leg ulcers. The solution employs a point-of-care wearable pressure sensing device that optimizes traditional compression therapy to reduce healing time, frequencies in healthcare visits, and costs to treat.

Visit website.

Predictive, personalized computational modeling and simulation solutions for structural heart interventions that empower medical device manufacturers to bring superior products faster to the market and enable physicians to improve clinical outcomes.

Visit website.

Fibralign's BioBridge Collagen Matrix is an FDA-cleared surgical mesh designed for use in soft tissue support and repair. BioBridge is fabricated using the company's patented Nanoweave technology, which utilizes 3D printing to create precise scaffolding which mimics human tissue nano structure to directly influence the body's innate repair function. The company is currently investigating BioBridge for use in treating secondary lymphedema. 

Visit website.

Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia. The company is building a purpose-built system that incorporates PFA, contact force sensing, electromagnetic localization, and artificial intelligence-enabled mapping capabilities to address the limitations of first-generation PFA technologies and deliver more efficacious therapy. 

Visit website.

Implantable Cardiac Output Management System (ICOMS) is a novel, wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart’s innate contractility.

Visit website.

Non-invasive sensors to improve the management of critically ill patients.

Visit website.

Flourish Medical has developed a single-use, disposable product to manage stress urinary incontinence. The company's device provides strap-like support under the urethra to compensate for weak natural support, without placing bulk in the lower vagina as seen with other products.

Visit website.

Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. Our innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently. Backed by years of laboratory research, a strong IP and tech transfer position, and contract manufacturing partners, the company is opening a $10M Series A round to launch human clinical trials.

Visit website.

Formus Labs has developed a software-as-a-service (SaaS) solution for use in orthopedic surgeries. The company's solution is an automated 3D planner for joint replacement surgeries that combines AI and computational biomechanics to created patient-specific surgical plans. The initial software solution is focused on hip replacement surgery.

Visit website.

Francis Medical is developing a minimally invasive treatment for several types of cancer. The company's technology utilizes water vapor and convection to evenly distribute energy through the target area and uniformly ablate tumor cells. Types of cancers that can benefit from this type of treatment include bladder, kidney, and prostate cancer. 

Visit website.

Free Flow Medical is developing novel solutions for the treatment of chronic respiratory illnesses, including bronchitis, emphysema, and COPD. The company's lead products are the FreeFlow Coil for severe emphysema patients and the FreeFlow Valve System for COPD. 

Visit website.

Freespira is a medication-free, FDA-cleared digital therapeutic treatment proven to significantly reduce or eliminate symptoms of panic disorder, panic attacks and post-traumatic stress disorder in just 28 days. Health plans, providers and self-insured employers use the company’s solutions to improve quality of life and to support the appropriate use of valuable healthcare resources.

Visit website. 

Frond Medical is developing a breakthrough technology platform that allows highly precise positioning of diagnostic and therapeutic devices in real-time for interventional procedures. This improved accuracy translates into better clinical outcomes, faster procedures, reduced waste, minimized radiation exposure and contrast agent usage, and improved hospital financials.  

Visit website.

Accelerating surgical capability for life science businesses via precision VR simulation.

Visit website.

Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures. 

Visit website.

Gleamer's vision is to empower radiologists with AI solutions for a wide range of clinical applications. The company's first product, BoneView, is an AI companion intended to provide preliminary data for bone trauma diagnoses based on standard radiographic images. The software functions as a second set of eyes, detecting potentially missed lesions, fractures, effusions, and dislocations in X-Ray images. Gleamer is currently developing additional products intended to cover 70% of a radiologists routine.

Visit website.

Glycologix is developing a non-systemic, highly cross-linked chondroitin sulfate-based biopolymer platform for soft tissue protection and repair. The company's biopolymers mimics naturally occurring proteoglycans and can be tailored to protect and repair specific tissue types. Glycologix's lead indication is for interstitial cystitis/bladder pain syndrome, with additional indications for dry eyes, surgical adhesion prevention, OA, disc disease, and wound repair in the company's pipeline.

Visit website.

GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complication while optimizes therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTile's provide uniform radiation-source spacing to ensure even dose distribution. 

Visit website.

GT Metabolic is pioneering a new approach to GI surgery. The company is using magnetic compression technology, which requires no cutting or retention of foreign material, to create anastomoses. The use of magnetic delayed anastomosis technology creates a unique opportunity to facilitate natural healing while reducing morbidity and mortality of metabolic and bariatric surgeries.

Visit website.

Gyder Surgical's Gyder Hip System is a non-invasive, pin-less navigation solution for total hip replacement. The system is an open platform that can be used with a surgeon's preferred implant system, reduces radiation exposure by not requiring CT or X-ray imaging, and seamlessly integrates into existing workflows due to the system's simple set-up and quick calibration.

Visit website.

Harmonic Bionics is a robotics company developing exoskeleton solutions to improve and rehabilitate movement impairments due to neurological and musculoskeletal disorders. The company's lead product, Harmony SHR, is a bilateral, upper-extremity exoskeleton designed to optimize upper-extremity rehabilitation.

Visit website. 

Healium medical is focused on advancing atrial fibrillation treatment with an innovative, no-contact guided ablation technology that allows simultaneous tissue ablation and lesion monitoring. The company's Echomplish platform features miniature transcatheter ultrasound technology to deliver precise ultrasonic energy for safe and rapid lesion formation. 

Visit website.

HealthySole is the pioneer and technology leader in reducing the pathogen load in settings where pristine environments are required: hospitals, compounding pharmacies, pharmaceutical R&D and manufacturing, food handling, and even EMS and law enforcement.

Visit website.

Hemideina is utilizing its proprietary technology to develop a wireless implantable hearing aide. The Hera Wireless Implant addresses limitations of current cochlear implants by consisting of two components - an internally implanted component and an external ear-bud - which utilizes Hemideina's sound processing technology to produce natural hearing with reduced background and environmental noise.

Visit website.

HEPATIQ's software analyzes images from nuclear medicine scans to provide quantitative liver function. The company's software runs on local workstations, integrating with PACS to analyze images and prepare a report for review by the radiologist/nuclear medicine physician. 

Visit website.

Histologics is committed to advancing the field of tissue sampling and care during colposcopic procedures and also advanced wound care. The company was established to improve histological sampling in women with abnormal cervical cancer screenings and has expanded to debridement and diagnostic tissue sampling for most chronic wounds. At the core of the company's solutions is a proprietary medical fabric, Kylon, which is comprised of fenestrated loops that create unique hooks woven into nylon fabric. The fabric functions as a system to collect and contain tissue samples and remove or debride devitalized tissue gently from wounds, and can be applied to any device contour, shape, or tissue surface. The technology is also in development for genomics, dermatopathology, lower GI diagnostics, tissue therapy, and several other applications.

Visit website.

IBEX Medical Analytics has developed an AI-driven diagnostic system which delivers efficient, metric-driven, and accurate cancer diagnoses for tissue biopsies. It combines AI, data science, image analysis and Deep Learning technologies and applies them to cancer diagnostics in digital pathology, impacting pathology lab efficiency, patient outcomes and quality of life. 

Visit website.

IKONA is a learning science company powering education in the management of chronic diseases, with an initial focus on chronic kidney disease (CKD). The company's initial pipeline of solutions includes VR software applications to educate dialysis patients and train providers. These solutions have been demonstrated to reduce patient anxiety, increase their knowledge of how to better manage their condition, and improve medication adherence.

Visit website.

Image Navigation creates solutions to improve dental care. The company's flagship product, Image Guided Implantology (IGI), utilizes CT scans and presurgical planning to guide dental implant placement. The IGI system is intended to reduce procedure time, support the surgeon, and minimize postoperative morbidity. Image Navigation also offers DentSim - an augmented reality dental simulation to help dental students hone their skills. 

Visit website.

Imago is pioneering the development of Visual Intelligence (VI), a novel image analysis solution to support tissue visualization, characterization and analysis for diagnosis. The Software as a Service (SaaS) solution differentiates tissues based on their geometric properties in X-ray, PET, and MR images. 

Visit website.

ImmersiveTouch is seeking to transform the capabilities of physicians to improve patient outcomes. ImmersiveView VR converts medical images into a digital twin that can be interacted with in virtual reality (VR). The company's technology is compatible with all major VR platforms. 

Visit website.

Graphene core technology designed to decode brain signals into medical solutions in the field of neuroelectronic therapies with the objective to restore patients' quality of life in those affected with brain-origin disorders. The company is developing a minimally invasive neural interface which will initially serve patients with epilepsy and Parkinson's disease.

Visit website.

Inner Cosmos' digital pill is a subcutaneously implanted brain-computer interface (BCI) to rebalance the brain. The device delivers precision micro-stimulations to focused networks within the brain, without the need for invasive neurosurgery that is typically required by other neuromodulation devices. The company is initially focused on developing their solution for the treatment of depression. 

Visit website.

Innoventric id developing an easy-to-use, reliable, and safe percutaneous solution for the treatment of tricuspid regurgitation. The company's Trillium device uses cross-caval anchoring and a unique, multi-valve design to fit a wide range of anatomies without the risks of migration and leaks. 

Visit website.

Designer and manufacturer of medical simulation products.  Core range of simulators includes ‘take-home’ laparoscopic simulators and a range of institutional based laparoscopic simulators. The company offers a growing range of simulators for teaching skills in critical care, medicine hysteroscopic and general surgery.

Visit website.

Intelligent Implants is working on the future of electrotherapeutic orthopedic devices. The company's mission is to develop a portfolio of smart, cloud-connected implants that can accelerate, control, and remotely monitor bone growth. Intelligent Implant's lead product is the SmartFuse System, which combines the company's proprietary electrotherapeutic technology platform with an intervertebral spacer to improve outcomes in lumbar spinal fusion procedures.

Visit website.

INVENIO's NIO Laser Imaging system uses Stimulated Raman Histology to image unprocessed tissue specimen without requiring sample preparation to enable histological evaluation of tissue outside of a laboratory. 

Visit website.

InVera Medical is developing a catheter-based therapy for chronic venous disease.  The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels.

Visit website.

Invizius' mission is to transform care with patients receiving dialysis or other extra-corporeal treatments. A leading cause of complications with extra-corporeal circuits is the repeated inflammatory insult to the cardiovascular system provoked by the procedure itself. Invizius's H-Guard priming solution is an alternative to saline for use with dialysis machines. H-Guard integrates with current setup procedures and prevents the inflammatory reaction on patients and the ensuing complications, costs and mortality.

Visit website.

IRRAS is a commercial medtech company focused on developing innovative solutions to improve the management of post-operative fluids. The company's lead product, IRRAflow, is a next-generation intracranial fluid management system that features a dual lumen catheter and control unit to manage the drainage of excess fluid and intracranial pressure. 

Visit website.

iSono's ATUSA is an AI-powered portable and automated 3D breast ultrasound scanner. The device is capable of automatically capturing the entire breast volume in 2 minutes, enabling repeatable breast ultrasound imaging at the point of care without requiring a trained ultrasound operator.  

Visit website.

Karios is a medical device company with a versatile technology platform that we are using to address large unmet needs in surgery and drug delivery. The company has developed a proprietary biogel to prevent scar tissue from forming between two tissues - a post-surgical complication known as an adhesion. Karios' initial focus is protecting children with congenital heart defects and adult cardiac surgery patients. Beyond the cardiac space, the company's technology has applications in OB/GYN and orthopedic procedures.

Visit website.

Kneevoice has designed a platform technology to capture the noise generated by the knee to evaluate cartilage damage and diagnose osteoarthritis. The platform consists of wearable knee sensors that records the sounds generated by the knee. This data is collected an analyzed by a neural network algorithm and generates a score evaluating the status of the cartilage.

Visit website

Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's. Kurve has completed Phases I, II, IIB and is Phase III ready in MCI. Kurve successfully delivers our proprietary medications through the blood brain barrier with a next generation drug delivery technology. Kurve brings revolutionary new treatments for CNS disorders through technology and drugs that modify the disease, creating breakthrough successes in medication effectiveness and quality of life. With demonstrated clinical efficacy, Kurve is changing the landscape of CNS therapies.

Visit website.

Lazurite's ArthroFree system is a wireless surgical camera designed to address the limitations of traditional arthroscopic camera systems. Lazurite's technology removes the need for fiber-optic cables, helping to improve efficiency without compromising image quality. At the heart of the company's technology is the proprietary Meridiem light engine, a novel light source that does not require cables to transmit light and images during surgical procedures. 

Visit website.

Lazzaro Medical has developed a minimally invasive surgery for the treatment of Tracheobronchomalacia (TBM), a degenerative disease that causes the complete, or near-complete, collapse of the airway due to cartilage breakdown in the trachea. The LM Scaffold System restores the patency of the trachea, improving breathing through a simple procedure conducted via a robotic system. The company is pursuing a platform approach to the treatment of TBM and other pipeline indications with the development of a diagnostic tool to simplify diagnosis and an endotracheal tube to improve the efficiency of respiratory surgeries.

Visit website.

Since 1982, Leonhardt Ventures has been a leader in developing medical devices and biologics. The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics. Leonhardt works within Brain, Cancer, Cosmetic and Personal Care, Major Organ Regeneration, and Heart & Cardiovascular. Over 600,000 patients have been treated with Leonhardt inventions to date. 

Visit website.

The Levita Magnetic Surgical System is an innovative technological platform that utilizes magnetic retraction designed to grasp and retract tissue and organs in laparoscopic cholecystectomy procedures to facilitate access and visualization of the surgical site. Levita Magnetic has implemented this technology into a robotic platform to assist in the performance of laparoscopic surgeries.

Visit website.

LimFlow is developing a minimally invasive solution to bypass blocked peripheral arteries, restoring blood flow to the foot. The LimFlow Percutaneous Deep Vein Arterialization System is a new treatment for patients with Chronic Limb-Threatening Ischemia (CLTI) that will reduce amputations, promote wound healing, and resolve pain.

Visit website.

Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops.

Visit website.

Liva Healthcare are digitizing personal healthcare. The company's digital health platform provides users with personalized coaching and tailored lifestyle plans. Currently the company offers digital programs for weight management and diabetes prevention.

Visit website.

Locate Bio is working to solve some of the most complex degenerative and infectious diseases that affect the muscular skeletal system. Locate utilises Programmed Drug Release to re-align the bioavailability of existing drugs with the underlying biological need. This bio-optimisation step has demonstrated break through improvements in performance in preclinical testing.

Locate Bio’s lead product, LDGraft, is entering human clinical studies next year, for the treatment of chronic lower back pain caused by degenerative disc disease. CognitOss Gel is in developed to overcome bacterial biofilm infections around non-viable tissue and orthopaedic implants.

Visit website.

Lumeda is developing DigiLum, a light dosimetry solution that utilizes artificial intelligence (AI) and photonics to activate a photosensitizer drug and deliver photodynamic therapy for the treatment of Non-Small Cell Lung Cancer (NSCLC). The DigiLum system enables a fast and simplified treatment that is automated to ensure ease-of-use, repeatability, and efficacy. 

Visit website.

Lumicell is focused on innovative fluorescence-guided technologies for cancer surgery. The company's Lumicell Direct Visualization System is intended to guide the removal of residual cancer during surgery in real time. The platform technology consists of an optical imaging agent, a handheld device, and patient-calibrated tumor detection software that work together to find, view and guide the resection of residual cancer. Lumicell is currently investigating the use of its technology for use during breast cancer surgery.

Visit website.

Lymphatica Medtech is a clinical stage company developing a permanent implant for the treatment of chronic lymphedema. The company's LymphoDrain device utilizes a subcutaneously implanted micro pump and catheter to evacuate accumulated lymph away from lymphatic obstructions and towards functional lymph nodes. The pump functions without the need for implanted electronics, utilizing an external magnetic field housed in a wearable controller to activate the internal magnetic pump.

Visit website.

MACH32 is developing innovative medical devices to address global health problems. The company's IMSAFE device is a large-volume intramuscular autoinjector designed to deliver large quantities of medication in a safe and efficient manner. ACT (Aerosol Containment Tent) is a solution that creates a negative pressure environment zone around a patient's head, neck and shoulders to prevent the spread of infectious aerosol particles to uninfected individuals and healthcare providers.

Visit website.

MaskZero is developing a personal protective device proven to kill microorganisms at the point-of-breath. Designed for all-day comfort, fit, and clear communication, MaskZero can limit mass transition of future microorganisms, thus allowing hospitals and other essential services to remain operational. The company's product is also intended to be an affordable, step-change to antiquated and ineffective PPE.

The IntelliSense Drill is an innovative handheld robotic technology which can change the standard of care in orthopedic procedures.

Visit website.

Medality Medical is developing a proprietary device intended to reverse Type 2 Diabetes and associated obesity. The device gently and selectively extracts excess mesenteric visceral fat, which has been associated with insulin resistance, to reverse insulin resistance. The technology uses tissue liquification technology to liquify adipose tissue which is then extracted via a vacuum mechanism. 

Visit website.

Developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.

Visit website.

Medical Magnesium develops bioresorbable implant technologies for orthopedic and trauma surgery. The company's mm.X technology platform consists of bioresorbable implants made of magnesium. Products under the mm.X platform include interference screws, suture anchor systems, and compression screws, and implants for the treatment of hammer and claw toes. Medical Magnesium is currently developing a system for the repair of foot fractures. 

Visit website.

Medinbox has developed a real-time, smart collaboration solution for use in the operating room and cathlab. The technology is designed to be easily operated and seamlessly integrate into the existing medical environment. Medinbox can utilize up to 16 imaging inputs to open up the OR for remote proctoring, support, and training & education. The company's solution is intended to simplify recording, live streaming, and collaboration.

Visit website.

MedOnect is developing a novel therapeutic for the treatment of cancers of the blood. The company's MedOnect Life Treatment Vest uses electronic ultrasound to generate specific frequencies of electric signals that propagate through the body to disrupt cancerous cell function and facilitate the regeneration of healthy cells. 

Visit website.

Mercator is developing local and targeted micro-infusion solutions for diseases of the peripheral vasculature. The company's Bullfrog Micro-Infusion Device is capable of infusing diagnostic and therapeutic agents into the vessel wall, perivascular area, or intraluminally to address Deep Vein Thrombosis (DVT) and Below the Knee (BTK) Peripheral Artery Disease (PAD).

Visit website.

Micro Interventional Devices, Inc. (MID) is a development stage medical device company focusing on the design, manufacture and commercialization of disruptive technologies for use in percutaneous structural heart repair procedures.  

Visit website.

Micro-Leads' Expand-X is a needle-injected nerve stimulator that self-expands to blanket a nerve target with precision therapy. The technology is designed as an alternative to current neurostimulators which require invasive surgeries to treat a wide range of conditions, from chronic pain, obstructive sleep apnea, and heart failure. In addition to targeted nerve stimulation, the company is developing proprietary Smart-Lead technology to restore walking and lower-limb control in paralyzed spinal cord injury patients.

Visit website.

MicroTransponder's Vivistim tool treats patients who experience upper limb problems after a stroke by delivering a small amount of neurostimulation to the vagus nerve to strengthen neural pathways in the brain during rehabilitation. The device comprises a small implanted battery and wires that internally connect to the vagus nerve in the neck. In addition to the Vivistim system, the company is evaluating its Serenity system as a treatment to treat and reduce tinnitus over time. 

Visit website.

MIMOSA has developed a tiny, hand-held device that democratizes the collection of tissue information in patients with peripheral vascular disease (PVD), wound care, diabetes, burns, and potential post-operative surgical complications. The device is capable of detecting tissue oximetry and temperature through the use of multispectral imaging, letting healthcare providers visualize beneath the skin, regardless of the patient's location.

Visit website.

Mirai Medical ePORE therapy is a unique precision therapy platform that targets and destroy tumor tissue without harming surrounding healthy tissue. The minimally invasive technology delivers pulsed electrical fields that create pores in the cell membrane of tumor cells, catalyzing cellular death. Mirai's technology has been developed for external (skin) and internal (endoscopic) tumor treatment. 

Visit website.

MOLLI Surgical started in the OR after recognizing that surgeons were using dated technologies to treat cancer patients. The company's technology eliminates the need for wires and radioactive seeds for tumor localization with a magnetic-based system that is precise, reliable, and easy-to-use.

Visit website.

Mosie is simplifying home insemination for couple's seeking to become pregnant. Mosie is a syringe designed to improve intravaginal insemination (IVI) and deliver sperm near the cervical opening and improving pregnancy odds. The Mosie syringe has been designed to overcome the limitations of standard syringes used for IVI, with a modified barrel and angular opening to safely deliver sperm.

Visit website.

Innovative solutions to address unmet needs in GI endoscopy, cost-effectively improving clinical outcomes that benefit patients, providers and payers worldwide.

Visit website.

MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.

Visit website.

myBiometry is a platform technology to remotely monitor and manage patients with chronic conditions. The initial application for the company's technology is monitoring asthma, a chronic respiratory condition where treatment failures can cost the patient and healthcare system severely. Through a combination of machine learning, a proprietary single-use sensor and measurement device, the company is collecting and monitoring biomarker data to understand treatment efficacy, adherence, and risk of costly asthma attacks. 

Visit website.

Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3D printing to create an implant which can permanently repair debilitating joint injuries. The implant can bear loads like a traditional joint implant, quickly restoring a patient’s movement.

Visit website.

Nanocrine is developing a next generation live cell imaging technology platform that enables the real time monitoring of cell protein secretions spatially and temporally. The platform is at the prototype stage with first patents issued. The company is currently bringing to market novel surfaces for live cell monitoring.

Visit website.

Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement.

Visit website.

NeoPredix is utilizing digital health solutions and intelligent algorithms to support maternal, neonatal, and perinatal care. The company's prediction software will support clinical decision makers, allowing them to personalize and optimize patient care based on deep medical data and science. 

Visit website.

Developing and commercializing our fully implantable continuous dialysis device - The Holly.

Visit website.

Therapeutics product designed for administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves. Also developing a suite of advanced microsurgical instruments for use in peripheral nerve surgery.

Visit website.

NeuraStasis is developing a novel device to increase the amount of time available to providers to treat patients suffering from ischemic stroke. The device stimulates the body's natural neuroprotective reflexes to preserve brain tissue and give healthcare vital time to treat and prevent stroke-related disability.

Visit website.

Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration.

Visit website.

NeuronSphere is a cloud & data focused Platform Development Kit that delivers infrastructure, ingestion, analytics, machine learning and data pipelines that make medical devices faster and more intelligent. 

Visit website.

NeuroSigma's Monarch external trigeminal nerve stimulation (eTNS) device is an innovative, medication-free treatment alternative for children with ADHD. The handheld device connects to a disposable patch that delivers low stimulating pulses to the trigeminal nerve overnight to regulate areas of the brain linked to ADHD. 

Visit website.

New View Surgical, Inc. is an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery. The VISIONPORT™ platform is a novel surgical visualization and access system that aims to simplify and cost-reduce the technology required to perform minimally invasive abdominal and thoracic procedures. The company's mission is to increase access to minimally invasive techniques for patients around the world.

Visit website.

NEXT Life Sciences is a medical device company that plans to deliver a non-hormonal, long lasting, and reversible male contraceptive solution empowering men and their partners to choose if and when to have a child. Leveraging a robust IP portfolio and decades of pre-clinical research, the company is now exploring a financing round in preparation for in-human trials.

Visit website.

NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night. Data collected will enable new insights and personalize treatments for neurological conditions and general mental well-being. 

Visit website.

Noninvasix is using optoacoustic technology to monitor critically ill patients in the hospital. The company is developing a non-invasive device monitor patients for sepsis and septic shock in real-time. The device will enable healthcare providers to rapidly diagnose, monitor, and respond to these life-threatening conditions in patients.

Visit website.

NousQ is developing CLiKX, a new approach to the insertion of ventilation tube insertion in children with otitis media with effusion - condition which affects the hearing of millions of children worldwide. When conservative treatments fail, a child will typically have small ventilations tubes inserted to drain fluid from the middle ear. CLiKX takes the surgical approach to treating this condition out of the OR and into the clinic. The handheld device features robotics and automated features to safely insert tubes without the need for microscopic visualization and general anesthesia.

Visit website.

NovaResp is developing technology to improve the prediction of respiratory events in patients using positive airway pressure (PAP) machines. The company's platform uses artificial intelligence and machine learning to monitor respiration and prevent detrimental episodes of apnea. 

Visit website.

Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation.

Visit website.

Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.

Visit website.

NSite has developed a radiation-free solution to screen and monitor adolescent scoliosis. The company's technology can be deployed via a smartphone or tablet, enabling real-time, non-invasive scans and assessment of bone and joint health. 

Visit website.

NuPulseCV's iVAS device is a blood pump designed to help patients with advanced heart failure. It works by using counterpulsation through a balloon-type device placed in the descending aorta. The device is meant to reduce pressure that the heart must work against, making it easier for the heart to pump blood to the body. 

Visit website.

Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software. 

Visit website.

3D imaging in surgery using AI image creation algorithms that merge prior information with real-time data gathered during surgery to reduce imaging time and to minimize x-ray radiation.

Visit website.

NZ Technology is a medtech company specialized in the design and manufacture of advanced Human Machine Interaction products. The company's TIPSO device enables convenient, over-the-drape controls for physicians to navigate live and historical imaging records during surgical procedures. NZ Technology's HoverTap technology is a touchless solution for navigating device menus and elevators.

Visit website.

Onkos Surgical delivers high quality implants and instruments that meet the unique needs of musculoskeletal tumor patients.

Visit website.

OPUM’s Digital Knee® is the first digital standard for musculoskeletal remote monitoring. Born out of ten years of academic and clinical R&D, OPUM has productized a universal sensor that can be deployed to examine the health of any joint from acute injuries to osteoarthritis maintenance and total joint replacement surgery.

The true value of OPUM's platform is providing digital examination with high levels of clinical accuracy, whilst being extremely easy to deploy and run in the field by clinics, staff and patients. OPUM is collaborating with leading US clinics, hospitals, orthopedic manufacturers and some of the world's most prestigious healthcare organizations to deliver the standard in remote monitoring.

Visit website.

Otolith is developing a wearable device for the treatment of vertigo. The device delivers a precise level of mechanical stimulation to the acceleration sensors of the inner ear. The therapeutic vibration masks vertiginous signals from the vestibular system to alleviate vertigo symptoms.

Visit website.

OUI Medical's micro-peritoneoscope is a disposable, portable handheld scope that includes an integrated camera, screen, processor, battery and biopsy forceps. The technology enables peritoneoscopy under local anesthesia at the point-of-care. 

Visit website.

PacificMD Biotech is are harnessing augmented reality and artificial intelligence to develop solutions targeting ENT and respiratory interventions. The company's portfolio consists of multiple AI and AR solutions to enhance the information available to interventionists and improve outcomes. In addition to software-focused solutions, PacificMD's ENtVISION is a single-use, digital endoscopic system that aims to make endoscopy an affordable reality for everyone.

Visit website.

Pallianera Pharma is a clinical stage biotech company developing solutions for multiple markets, including aesthetics, oncology, orthopedics and pain management. The company's pipeline currently consists of two products - Evangeline, a biostimulator for cosmetic and dermatological applications and Chrondrostem, a biologic regenerative scaffold for degenerative disc disease and osteoarthritis. Pallianera's Evangeline technology has also been combined with hyaluronic acid (HA) to treat fine lines and wrinkles. 

Visit website.

PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment.

Visit website.

Developing and commercializing the Phagenyx platform, which consists of a treatment catheter and base station. Introduced through the nose, the Phagenyx catheter delivers electrical stimulation to the throat to treat dysphagia (difficulty swallowing). 

Visit webiste.

PherDal is making at-home fertility care affordable, safe, and effective. The company's sterile kits are designed to be easy-to-use and offer an alternative to expensive fertility treatments for families trying to conceive. PherDal is working with the FDA to become the first FDA-cleared at-home assisted reproduction kit. PherDal will provide the first over-the-counter fertility option to the 12.2 million women in the US looking for a safe fertility option to try before more invasive treatments. 

Visit website.

The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates.

Visit website.

PICS Therapeutics mission is to develop a next-generation cardiac assist device for the treatment of early stages of heart failure. The company is addressing the unmet needs of traditional ventricular assist devices through a solution that can be rapidly deployed for short-term cardiac support across multiple indications, including acute heart failure, acute decompensated heart failure, cardio-renal syndrome, cardiogenic shock, and other conditions.

Visit website.

Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.

Visit website.

Pontix Medical has developed a minimally invasive, next-generation nerve stimulation technology that targets the nerves involved in chronic migraine pain. The innovative device uses proprietary technology to uncouple the energy source from the neurostimulation implant - improving patient safety and quality of life.

Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration.

Visit website.

A predictive health company developing the next generation of medical devices with smart sensors and artificial intelligence. The company's Accuryn system transforms a Foley catheter into a real-time sensor of urine output, intra-abdominal pressure, and core body temperature to monitor risk of acute kidney injury. 

Visit website.

PrecisionOS develops software solutions that leverage extended reality to enhance surgical performance while accelerating the safe use of medical devices. The solutions are part of the digital surgery ecosystem helping to improve surgical outcomes through enhanced experiential pre-operative planning and training.

Visit website.

Pretika MedTech is reimagining outpatient and inpatient care with AI-powered Connected Wound Care technology.  The company's non-invasive, embedded medical device and wireless digital care cloud platform provides on demand or continuous imaging, sensor and data analytics for physicians and nursing teams to monitor post-surgery, wound and disease healing remotely or in-person without having to remove the surgical dressings, bandages, wraps or casts.

Visit website.

Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.

Visit website.

A secure, complete software solution which expands surgical collaboration enabling surgeons to share expertise using augmented reality tools before, during and after surgery.  

Visit website.

Wearable patch that utilizes ultrasound to continuously monitor cardiac output and performance. The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.

Visit website.

Next-generation beta ophthalmic applicator.

Visit website.

Radiatric was founded to develop and commercialize technologies to improve outcomes in patients with bacteremia, moderate to severe sepsis, and septic shock. The Radiatric RAD-01 system is an extracorporeal blood filtration system that uses visible light to eradicate pathogens and disinfect blood. The system is compatible with existing CRRT, dialysis, and hemoperfusion machines. 

Visit website.

Ranfac is an established specialty manufacturer of Class I and II single-use medical devices. Ranfac is able to provide one-stop, finished good services as both an OEM partner and contract manufacturer to the medtech industry, while also offering a range of Ranfac label devices across multiple specialties, including general surgery, hematology, radiology, and orthopedic access.

Visit website.

Visit website.

REACT Holdings have developed a complete muscle therapy system based on extracorporeal magnetic innervation (ExMI). The technology employs deep-penetrating gradient magnetic pulses that penetrate a patient's smooth and striated muscles, causing them to contract. The stimulation has therapeutic benefits for a number of indications, including pain management, neuromuscular rehabilitation, muscular atrophy, and range of motion restoration. 

Visit website.

RedDrop is a virtually pain-free, cost-effective, and easy-to-use whole blood and plasma collection system. The device, which can be used in home and healthcare settings, is capable of collecting high quality blood samples for diagnostic testing and remote clinical trials. 

Visit website.

Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients. Using the data from our monitor, clinicians implement proven protocols that reduce acute kidney injuries, myocardial injuries and other costly complications.

Visit website.

RevBio is using tetranite, a unique organic compound, as the base for its platform of bone adhesive biomaterials. The company's proprietary biomaterial is capable of multi-surface bonding, rapidly reaching mechanical stability, performing well in wet fields, and biodegrading at a controlled rate. RevBio's tetranite is under investigation for use in dental, cranial, trauma, spine, and animal health markets, with additional expansion opportunities identified.

Visit website.

Rivanna Medical are the makers of Accuro, and FDA-cleared device for epidural guidance. The device uses diagnostic ultrasound imaging to improve the efficiency, safety, and speed of neuraxial anesthesia procedures. The company's technology improves localization and eliminates the need for the palpation-based approach.

Visit website.

Ronovo Surgical is a Shanghai-based surgical robotics company. The company has been in stealth mode since 2019 and plan to unveil their expertise in robotic technologies focused on soft tissue surgery.

S-Alpha Therapeutics is a digital therapeutics company developing platform technologies to enable digital therapies for different chronic diseases. The company's lead product, SAT-001, is preparing for testing in clinical studies for the treatment of eye disease. Other indications under development include neurology, oncology, and gastroenterology. 

Visit website.

SafeHeals' Colovac is being developed to eliminate the need for diverting ostomies in patients undergoing colectomy. Colovac prevents the sequelae of anastomic leakage after colorectal surgery postoperative recovery during the critical 10-day postoperative healing stage.

Visit website. 

Samay uses a patented acoustic resonance technology to manage respiratory patients at-risk of exacerbations. Our first product, Sylvee, is a wearable sensor platform that continuously, passively and non-invasively monitors over 10+ lung function parameters in real time for 10x less than hospital-based testing

Visit website.

Non-invasive bio-therapeutic device for pain management.

Visit website.

Scanbo is developing a digital ecosystem driven by artificial intelligence to provide patients and healthcare workers with personalized health analysis and health management insights. 

Visit website.

Sentante is developing a teleoperated/remote surgical robot for the performance of fully-robotic endovascular interventions. Artificial intelligence (AI) will enhance the capabilities of the system, enabling the performance of routine tasks during interventional cardiology procedures such as guidewire and catheter exchanges. 

Visit website.

Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.

Visit website.

Simpson Interventions is an early-stage startup dedicated to the development of advanced, real-time image guidance solutions for cardiovascular interventions. The company's first solution is an integrated and augmented image-guided catheter for guidewire re-entry for the treatment of coronary chronic total occlusion. 

Visit website.

Sinaptica has developed a personalized closed-loop noninvasive neuromodulation therapy for Alzheimer’s Disease (AD). The company’s investigational SinaptiStim™ System represents a totally new approach to treating AD by enhancing neuroplasticity via precise, individualized neurostimulation of key brain networks involved in memory. Sinaptica has been granted FDA Breakthrough Designation based on unprecedented, published Phase 2 sham-controlled efficacy that achieved statistical significance on all four gold-standard cognitive & functional clinical endpoints.  

Visit website.

Single Pass has developed a patented, battery-powered, disposable electrocautery device for cauterizing deep tissue biopsy channels after solid organ biopsy procedures. With millions of biopsy procedure performed each year, it is difficult to determine which patients may bleed severely following the procedure. Current techniques have limited effectiveness in managing hemorrhaging, resulting in complications and increased costs for patients and healthcare providers. The Single Pass device addresses these challenges while also enabling the use of larger guide needles to collect larger samples in fewer passes. 

Visit website.

SIVA Therapeutics mission is to develop minimally invasive devices for cancer treatment. To achieve this goal, the company is developing a nanotechnology platform that utilizes targeted hyperthemia to heat and destroy solid tumors and spare healthy tissues. 

Visit website.

Sleepiz's mission is to provide patient-centric disease management through the implementation of contactless monitoring in the home. The company's technology leverages the power of sleep insights with a bedside device that measures movements from heart contractions, breathing patterns, and body motions with medical-grade accuracy. Sleepiz is currently focused on monitoring respiratory illnesses, with chronic disease monitoring being a future application for the platform.

Visit website.

Molecular breast imaging (MBI) technology to more accurately diagnose early-stage breast cancer in women with dense breast tissue. The Eve Clear Scan platform utilizes gamma cameras and intravenously injected cancer tracers to identify rapidly growing cancer cells that can potentially evade detection with traditional mammogram technology.

Visit website.

Smartlens has developed a device to enable "on the go" measurement of intraocular eye pressure. The company's flagship product, miLens, is an electronics-free device that provides seamless measurement capabilities to improve the early diagnosis of eye disease, certain neurological disorders, and cancers. In addition to the miLens product, the company's THERmic device applies micro-doses of personalized treatments for the treatment of glaucoma.

Visit website.

Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hi replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants.

Visit website.

Detecting flow compromise earlier using real-time, definitive, visual and quantitative blood flow monitoring — made possible with ultrasound.

Visit website.

The first osseointegrative biomimetic knee cartilage implant.

Visit website.

Spinal Stabilization Technologies PerQdisc Replacement System is an innovative, less invasive solution for lumbar spine disc nucleus replacement for the treatment of chronic low back pain due to degenerative disc disease. PerQdisc replaces the physical space of the nucleus, recreates the biomechanical motion, and redistributes weight-bearing forces in an anatomical fashion.

Visit website.

SpinTech MRI is dedicated to addressing clinical and operational challenges in magnetic resonance imaging. The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency. The solution integrates with virtually all MRI systems and manufacturers. 

Visit website.

Sterile Processing Express supports healthcare providers with retrieval, processing, and delivery of sterilized instrument trays. Ancillary surgical facility services, such as instrument sharpening, instrument use histories, and asset tracking are additional opportunities that will be available to SPDx customers due to the company's centralized location. 

Visit website.

Stimdia's pdSTIM system has been designed to electrically stimulate the phrenic nerves in a patient's neck to exercise the diaphragm during mechnical ventilation and minimize the impact of ventilation-induced diaphragmatic dysfunction. The temporary pacing stimulation is intended to support patients who have been ventilated for over 96 hours.

Visit website.

Stoparkinson's Earstim is a wearable electro-stimulation device intended to alleviate the symptoms of patients with Parkinson's disease without side effects.

Visit website.

User-friendly sensors, unique collection methodologies, and data processing software that creates a more holistic view of a patient's respiratory health.

Visit website.

SurePulse has identified a critical need for vital signs monitoring solutions for newborn babies. Current technologies have been adapted from devices for children and adults and are not suitable for newborn babies due to multiple factors. To address this limitation, the company has designed the SurePulse VS system, which uses a medical cap fitted with sensors to continuously monitor neonatal vital signs.

Visit website.

Switfsure Innovations is addressing the challenges in caring for ventilated patients in critical care. The company's first product is being developed to improve oral care and reduce the incidence of ventilator-acquired pneumonia and its associated complications due to poor oral care. 

Visit website.

Synapse Dental is the developer of the Dental Pain Eraser, a pen-shaped solution that prevents and alleviates oral pain, drug-free and within seconds of application for the dental office and home-use. It uses patented Pulse Wave technology that delivers subsensory electrical stimulus to disrupt the sensation of pain derived from dental procedures and oral disorders. It temporarily alters the mechanism of the biological pain cascade without numbness. 

Visit website.

Synova Life Sciencesis a biotechnology company that has developed a proprietary methodology and system for processing fat cells into autologous stem cells. Using Synova's approach, clinicians and researchers are able to obtain greater yields of stem cells 30 times faster than the current gold standard for stem cell harvesting.

Visit webiste.

Syntr Health Technologies is a developer of an automated microfat processing system to enable natural healing and rejuvenation. The company's technology, which can be used in a physician office, is currently FDA cleared for use in over 12 surgical specialities. The company seeks to commercialize first in the aesthetics and plastic surgery, with future commercialization in wound care, general surgery, orthopedic & arthroscopic surgery, and dermatology. 

Visit website.

TAS Medical's Tissue Approximation System is designed to simplify and enhance the surgical closure of soft tissue defects. The technology is being developed as an alternative to tying square knots, which can lead to soft tissue tears known as cheese wiring.

Visit website.

Telemeet offers a fully integrated telehealth solution for patient/provider communication. The platform integrates with current healthcare enterprise tools, including EMRs and planning tools. Telemeets technology secure stores a combination of recordings, transcriptions, and other document trails that can then be shared and reviewed with other healthcare providers.

Visit website.

Theator has developed a real-time video monitoring system for the operating room and then analyzes data using artificial intelligence (AI). The platform automatically connects with the EHR to reveal unique insights and reduce variation in outcomes in the context of both patients and surgeons.

Visit website.

THERYQ specializes in the design and production of linear accelerators for radiotherapy. The company's FLASH technology is intended to increase the effectiveness of radiotherapy, by taking the conventional radiotherapy process requiring multiple treatment sessions and weeks of irradiation and condensing it into a single procedure performed in milliseconds. The result of this high energy radiotherapy is a reduction in the side effects while simultaneously increasing treatment efficacy.

Visit website.

THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant.

Visit website.

TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging. The PHASER system verifies tumor and organ positioning and "freezes" motion as treatment is delivered.

Visit website.

Toetal Solutions is developing solutions to correct deformities of the foot and ankle. The company's lead product, Ziptoe, facilitates the surgical correction of hammertoes utilizing active compression of the PIP joint, while preventing rotation.

Visit website.

Total Joint Orthopedics was established to provide high quality orthopedic implants that also reduce the impact these products have on the healthcare system. To date, TJO hip and knee implants have been placed in over 34,000 cases. The company's newest innovation, Aurum, utilizes ballistically boned titanium nitride (TiN) to produce a hardened surface with superior wear characteristics compared to traditional cobalt chrome.

Visit website.

TrackX Technologies is enhancing surgical instrument tracking with real-time, virtual live fluoroscopy. The company's Snap device provide visual guidance and real-time instrument tracking of the jamshidi needle during percutaneous pedicle screw placement procedures. 

Visit website.

True Concepts Medical (TCM) technologies are designed by clinicians for clinicians, with a focus on areas that have significant morbidity and mortality, such as sepsis and sudden cardiac arrest. TCM’s first product to bring to market is D’VIA™️, which provides contaminant-free collection of blood cultures for accurate sepsis diagnosis. D'VIA™ is a 4-in-1 Dual Chamber Blood Collection System preventing expensive false-positives, false-negatives and process contamination. This is achieved by isolating pure, uncontaminated blood for faster, more accurate sepsis testing and diagnosis helping hospital ED’s/ICU’s protect revenue integrity, lower costs, and improve patient outcomes.

TrueCath is developing a device to streamline the insertion of peripheral intravenous catheters (PIVC). The device incorporates a mild vacuum in the flashback chamber which, upon entering the vein, senses the change in pressure and automatically deploys the soft gel IV catheter into the vein. Deployment is quick enough to prevent overpenetration, which is currently the major contributor of IV failures, due to technologic limitations of current PIVCs in the market. The TrueCath improves upon success rates of PIVCs placements by providing first-attempt, single wall venous access regardless of operator skill level and vein visualization.

Visit website.

Trukera Medical is building a portfolio of products to address unmet needs in eye care for patients and providers. The company's ScoutPro osmolarity system is a handheld osmolarity testing device for the detection of toxic hyperosmolarity, a condition which damages corneal cells and drives refractive instability. 

Visit website.

Founded in 1866, TUV SUD is a partner of choice for safety, security and sustainability solutions. The company works as a partner in certification and testing services for manufacturers and suppliers of medical devices and in vitro diagnostics.

Visit website.

TYBR Health is developing a natural hydrogel to prevent adhesions (internal scarring) that can occur following minimally invasive surgery. The technology is intended to reduce post-operative complications which can cause patients pain and require rehabilitation following tendon and joint surgeries. 

Visit website.

UpLyft is a self-transfer system for patients with limited mobility. The system is easy-to-operate and capable of moving a person from a bed to a wheelchair in 1 minute. 

Visit website.

US Medical Innovations is Engineering Plasma Physics to Fight Cancer…

We are a Global Company whose focus is developing cold atmospheric plasma and advanced robotic therapeutic devices for the eradication of cancer and the improvement of human lives.

Visit website.

Vascular Therapies is a biotechnology company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring an AV fistula for dialysis. The company's lead product, Sirogen, is being evaluated to address stenosis in AV fistula. Sirogen is a collagen-based implant that releases sirolimus at and around the site of the anastomosis for approximately 12 weeks, after which the collagen implant is bioabsorbed. 

Visit website.

Vena Medical is developing solutions to improve the way stroke is treated. The company's MicroAngioscope camera is capable of going inside the veins and arteries to visualize diseased lesions and help physicians treat stroke. The Vena BDAC system combines a balloon guide catheter with a distal access catheter to allow physicians to get closer to clots faster and more efficiently.

Visit website.

Vena Vitals is an early stage med-tech company focused on non-invasive continuous blood pressure monitoring. The company's proprietary technology is a soft flexible sensor that conforms to the skin for direct pressure measurement at theradial artery. The company's technology is intended to replace unnecessarily invasive arterial line measurements as well as non-continuous cuff-based methods in both the hospital and at home.

Visit website.

Veris Health is a digital health company developing the first intelligent implantable vascular access port with biologic sensors and wireless communication to improve personalized cancer care through remote patient monitoring.

Visit website.

Versono is developing an intravascular ultrasonic platform to improve the crossing of severe occlusions in the peripheral vasculature. The device will prepare a working lumen to support endovascular therapy in patients with chronic total occlusions (CTOs) and critical limb ischemia (CLI).

Visit website.

VESTECK Suture-Tight catheter secures endovascular aortic grafts to the aorta at the time of implant or during repair procedures.

Visit website.

Transforming surgery through robotics and virtual reality. The Vicarious Surgical robot will offer surgeons a 360 degree view and reach within the patient and surgical field.

Visit website.

VIDA is transforming lung care through intelligence, using imaging-based AI to uniquely profile and manage the patient with or at-risk of respiratory diseases. 

Visit website.

Virtonomy has developed an end-to-end digital twin and simulation solution to perform clinical development and testing in a virtual environment to accelerate development and reduce risks, expenses, and regulatory burdens. The company's virtual trial platform creates virtual patient cohorts based on real clinical data to reflect anatomical variability, demographic diversity, and pathological conditions. 

Visit website.

Visapath's mission is to build the next-generation pathology lab that increases accuracy, efficiency, and quality across critical lab processes. The company's lead product, Sentinel, automatically measures and images tissue samples in under a second. The system rapidly generates a detailed report - reducing the turnaround time on specimen analysis. 

Visit website.

Visura manufacturers the world's first, FDA-cleared, disposable camera, the TEECAD System, that seamlessly connects to a transesophageal echocardiogram (TEE) echo probe, providing physicians real-time visualization for more efficient and effective probe placement for safer intubation.

Visit website.

ViTAA is utilizing artificial intelligence to analyze computed tomography (CT) images to enhance the assessment of aneurysmal tissue. The AI solution, Regions of Aortic Weakness (RAW) is capable of color-coding and mapping abdominal aortic aneurysms based on the strength and weakness of the tissue, as well as identify calcium, thrombus, flow and strain to determine the risk of rupturing. 

Visit website.

WaveClear is harnessing the piezoelectric effect to generate ultrasonic energy for the treatment of occlusive vascular diseases. The company have developed a proprietary catheter-based system to deliver therapeutic wavelengths of ultrasonic energy to treatment areas. The technology is being evaluated for the selective ablation of peripheral thrombi and in the decalcification of heart valves.

Visit website.

Wearable Artificial Organs is developing truly portable solutions for use in patients with End Stage Renal Disease (ESRD). The company has currently prototyped two wearable device, a cordless continuous renal replacement therapy (CRRT) system and a wearable artificial kidney. 

Visit website.

Wondr Medical is creating a digitally connected health community on a global scale. Through the company's digital platform, the company seeks to accelerate collaboration, discovery, and innovation among the world's health networks. In addition to connecting the healthcare community, Wondr Medical collects thousands of educational videos to facilitate medical education.

Visit website.

YorLabs is developing a novel, image guided therapy solution. The company's intracardiac echocardiography (ICE) system is a zero-footprint, zero CapEx system that is intended to lower the barriers for device adoption by improving workflow, offering relief from large capital outlays, and offering superb image quality. 

Visit website.

Zentrela's mission is to transform the global drug industry development process through the quantification of the effects drugs have on the brain. The company has developed an EEG-based neurotech solution to evaluate the impact of pharmaceuticals on the brain that creates a clear understanding of how mental states are altered after drug exposure. The first commercial application for the company's neurotechnology is the evaluation of cannabis products to understand their psychoactive effects and improve their commercial success.

Visit website.

Zeto's electroencephalogram (EEG) is an FDA-cleared alternative to traditional EEG setups. The company has developed a wearable headset that is wireless, eliminates the need for preparation (e.g. gel application), and fully integrates with cloud data systems for real-time data viewing and management.

Visit website.

Combining advances in ultrasound and robotics, Ziteo Medical's mission is to reinvent medical imaging to detect cancer in its earliest stages. The company's technology will improve outcomes by enabling early detection, localization and treatment of cancer.

Visit website.

New procedure to mimic the clinical effects of tibial osteotomy procedures. Implants will be delivered to the proximal tibia below the patellar tendon, offloading and re-directing the tendon to reduce pain and inflammation.

Visit website.

ZygoFix develops and commercializes its zLOCK system, a proprietary technology that adds "bend-ability" to joints and provide natural stabilization. The technology is currently used to achieve spinal fusion and spinal stability without screws. 

Visit website.